Rapid Micro Biosystems (RPID) Research & Development (2020 - 2026)

Rapid Micro Biosystems has disclosed Research & Development across 7 years of filings, most recently posting $3.4 million for Q1 2026.

• Research & Development for Q1 2026 came in at $3.4 million, down 7.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.3 million (down 7.24% YoY), and the FY2025 annual result was $13.6 million, down 6.81% from the prior year.
• Research & Development came in at $3.4 million for Q1 2026 at Rapid Micro Biosystems, up from $3.2 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $3.8 million in Q1 2024 to a low of $3.0 million in Q2 2022.
• The 5-year median for Research & Development is $3.4 million (2026), against an average of $3.4 million.
• Across the five-year window, Research & Development surged 64.18% in 2022 and slipped 13.73% in 2025, its largest moves.
• Rapid Micro Biosystems' Research & Development stood at $3.4 million in 2022, then dropped by 2.5% to $3.3 million in 2023, then increased by 2.53% to $3.4 million in 2024, then decreased by 5.35% to $3.2 million in 2025, then gained by 4.32% to $3.4 million in 2026.
• The last three Research & Development figures came in at $3.4 million (Q1 2026), $3.2 million (Q4 2025), and $3.5 million (Q3 2025), per Business Quant data.